Publicado 4 números por año
ISSN Imprimir: 0893-9675
ISSN En Línea: 2162-6448
Indexed in
Antigen Processing/Presenting and Oncogenesis
SINOPSIS
It has been established in recent years that a number of tumor cell types express tumor antigens, yet the host's immune system fails to recognize them. The antigen processing/presenting machinery, which plays a crucial role in generating an immune response, and possible causes for its inability of processing/ presenting tumor antigens are reviewed. These causes are related to the expression of major histocompatibility complex molecules, costimulatory molecules, and tumor antigens by tumor cells, and the types of cytokines produced. Therapeutic measures include transfecting tumor cells with genes that encode major histocompatibility complex and costimulatory molecules, cytokines, and tumor antigens. In addition, tumor peptide vaccines are evaluated. However, developing an immune response to tumor antigens carries with it the risk of autoimmune disease.
-
De Vita Ferdinando, Orditura Michele, Galizia Gennaro, Romano Ciro, Infusino Stefania, Auriemma Annunziata, Lieto Eva, Catalano Giuseppe, Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies, Cancer, 86, 10, 1999. Crossref
-
Makkouk Amani, Abdelnoor Alexander M., The potential use of toll-like receptor (TLR) agonists and antagonists as prophylactic and/or therapeutic agents, Immunopharmacology and Immunotoxicology, 31, 3, 2009. Crossref
-
Eisenlohr Laurence C., Rothstein Jay L., Antigen Processing and Presentation, in Tumor Immunology and Cancer Vaccines, 123, 2005. Crossref